Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
03/1997
03/19/1997EP0762881A1 Method and reagents for the treatment of rheumatoid arthritis
03/19/1997EP0659191A4 Cloning and expression of pur protein.
03/19/1997EP0626861B1 Treatment for asthma
03/19/1997EP0445135B1 Immogenically active fractions of borrelia burgdorferi
03/19/1997CN1145641A DNA mutagenesis by random fragmentation and reassembly
03/19/1997CN1145640A Method for detection of methylthioadenosine phosphorylase deficiency in mammalian cells
03/19/1997CN1145636A Vascular endothelial growth factor 2
03/19/1997CN1145369A Peptide useful as ligand
03/19/1997CA2182541A1 Novel, ubiquitous potassium-channel proteins and genes for the same
03/19/1997CA2181880A1 Atp-sensitive potassium-channel proteins and their genes
03/18/1997US5612895 Method of rational drug design based on ab initio computer simulation of conformational features of peptides
03/18/1997US5612486 Transgenic animals harboring APP allele having swedish mutation
03/18/1997US5612459 Production and characteristics of anti-teicoplanin polyclonal antibody
03/18/1997US5612458 Antibody to PNA/nucleic acid complexes
03/18/1997US5612332 Inhibiting protein glycosylation
03/18/1997US5612216 Nucleotide sequence encoding intercellular adhesion molecule-1 and fragments thereof
03/18/1997US5612205 Producing dna segments
03/18/1997US5612201 Genetic engineering and kits for determination of gene expression
03/18/1997US5612195 Recombinant production of a human interferon (IFN)-gamma antagonist cytokine
03/18/1997US5612182 Mycobacteriophage specific for the mycobacterium tuberculosis complex
03/18/1997US5612042 Vaccine against streptococcus suis infection
03/18/1997US5612036 Crosslinked polypeptide vaccine with cysteine groups and carriers
03/18/1997US5612034 Super-globuling for in vivo extended lifetimes
03/18/1997US5612033 Methods of treatment using heat-treated IGM antibody preparations
03/18/1997US5612032 Method for diagnosing tumors using mouse monoclonal antibodies
03/18/1997US5612031 Dentistry
03/18/1997US5612030 Anti-idiotype monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma
03/18/1997US5612016 Conjugates of antibodies and bifunctional ligands
03/18/1997CA2031528C Radionuclide metal chelates for the radiolabeling of proteins
03/13/1997WO1997009436A1 Method for producing phage display vectors
03/13/1997WO1997009433A1 Cell-cycle checkpoint genes
03/13/1997WO1997009432A1 Cyclin-dependent kinase
03/13/1997WO1997009429A2 Compounds and methods for diagnosis of tuberculosis
03/13/1997WO1997009427A1 Vegf-related protein
03/13/1997WO1997009425A1 Cerebellum-derived growth factors, and uses related thereto
03/13/1997WO1997009418A1 Transcriptional co-repressor that interacts with nuclear hormone receptors and uses therefor
03/13/1997WO1997009351A1 Recombinant anti-cd4 antibodies for human therapy
03/13/1997WO1997009349A1 Binding protein
03/13/1997WO1997009345A1 Virus protein purification from virosomes
03/13/1997WO1997009343A2 Antagonists of the oncogenic activity of the protein mdm2, and use thereof in the treatment of cancers
03/13/1997WO1997009341A1 Cyclin e variants and use thereof
03/13/1997WO1997009065A1 Remedy for autoimmune disease
03/13/1997WO1997009063A1 Uses of tfpi inhibitor for treatment of cancer
03/13/1997WO1997009055A1 Isolation of microdomains of caveolae and gpi-anchored proteins
03/13/1997WO1997005256A3 Mammalian pro-hormone convertase
03/13/1997WO1997005170A3 Broad specificity antibodies
03/13/1997WO1996040041A3 Antibodies to fas antigen capable of inhibiting apoptosis
03/13/1997WO1996034964A3 Stable variant hk2 polypeptide
03/13/1997WO1996033279A3 Repertoire cloning process, products derived therefrom and uses for said products
03/13/1997CA2231400A1 Vegf-related protein
03/13/1997CA2231190A1 Cell-cycle checkpoint genes
03/13/1997CA2231182A1 Recombinant anti-cd4 antibodies for human therapy
03/13/1997CA2231045A1 Method for producing phage display vectors
03/13/1997CA2230927A1 Compounds and methods for diagnosis of tuberculosis
03/13/1997CA2230858A1 Transcriptional co-repressor that interacts with nuclear hormone receptors and uses therefor
03/13/1997CA2230795A1 Cyclin e variants and use thereof
03/13/1997CA2228667A1 Antagonists of the oncogenic activity of the protein mdm2, and use thereof in the treatment of cancers
03/13/1997CA2228604A1 Isolation of microdomains of caveolae and gpi-anchored proteins
03/13/1997CA2227301A1 Hcv binding protein
03/12/1997EP0761819A1 Exopolysaccharides of burkholderia pseudomallei and burkholderia mallei
03/12/1997EP0761814A1 Antibody 103 B2 to a peanut agglutinin(PNA)-binding glycoprotein on cell surfaces
03/12/1997EP0761688A2 Production, and therapeutic combinations, of antibodies
03/12/1997EP0761687A1 Process for preparing antibody
03/12/1997EP0761685A2 Macrophage-derived inflammatory mediator (mip-1 alpha and mip-1 beta)
03/12/1997EP0761233A2 Transkaryotic implantation
03/12/1997EP0761232A1 Antiallergic agent comprising anti-PAF receptor antibodies
03/12/1997EP0761034A1 Electromagnetically controlled gear engagement mechanism integrated with a magnetic hysteresis slip clutch
03/12/1997EP0760864A1 Dna encoding glutamate gated chloride channels
03/12/1997EP0760857A1 Receptor for oncostatin m
03/12/1997EP0760852A1 Immunosuppressant target proteins
03/12/1997EP0760851A1 Tumor necrosis factor receptor-associated factors
03/12/1997EP0760850A1 P2x RECEPTORS (PURINOCEPTOR FAMILY)
03/12/1997EP0760823A1 CLONED $i(LEPTOSPIRA) OUTER MEMBRANE PROTEIN
03/12/1997EP0760685A1 Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy
03/12/1997EP0760601A1 Predicting fetal membrane rupture by mmp-9 activity
03/12/1997EP0538283B1 Synthetic peptides and mixtures thereof for detecting hiv antibodies
03/12/1997EP0489048B1 Inhibition of tumor growth by blockade of the protein c system
03/12/1997CN1145077A Immuno-stimulatory monoclonal antibodies
03/12/1997CN1145076A Prostaglandin I2 receptor
03/12/1997CN1145032A Monoclonal anbibodies which bind to tumor rejection antigen precursor MAGE-1, recombinant MAGE-1, and MAGE-1 derived immunogenic peptides
03/11/1997US5610288 Antisense polynucleotide inhibition of epidermal human growth factor receptor expression
03/11/1997US5610283 Opiate derivatives and protein and polypeptide opiate derivative conjugates and labels
03/11/1997US5610282 cDNA encoding a rat D1 dopamine receptor linked to adenylyl cyclase activation and expression of the receptor protein in plasmid-transfected cell lines
03/11/1997US5610281 Monoclonal antibody which specifically binds to human e-cadherin
03/11/1997US5610280 Antitumor
03/11/1997US5610279 Human TNF receptor
03/11/1997US5610276 Determination whether a cell is cancerous
03/11/1997US5610058 Cytotrophoblast antigen and monoclonal antibodies which specifically bind cytotrophoblast cells
03/11/1997US5610057 Monoclonal antibody specific for IgA receptor
03/11/1997US5610035 Methods for the preparation of hybridomas producing lymphadenopathy-associated virus (LAV) GP110-specific monoclonal antibodies and methods for the purification of GP110 employing said monoclonal antibodies
03/11/1997US5610034 Immunoglobulin production by trichoderma
03/11/1997US5610024 Contacting sample with activated protein c and reactants for determining antihemophilic factor activity; incubation, evaluation
03/11/1997US5610023 Method of purification of clostridium difficile toxin A and production of mono-specific antibodies
03/11/1997US5610021 Compositions and methods for identification and use of soluble complex forms of osteogenic proteins
03/11/1997US5610018 Mitogenic signal transduction pathway
03/11/1997US5610011 Virulence-encoding DNA sequences of Strepococcus suis and related products and methods
03/11/1997US5610009 Mammalian expression systems for hepatitis C virus envelope genes
03/11/1997US5609872 Peptides comprising a protective epitope from blood stages of plasmodium falciparum
03/11/1997US5609870 Antisecretory, immunology
03/11/1997US5609869 For use in diagnosis and therapy